Total Payments
$5,148
2024 Payments
$572.84
Companies
20
Transactions
182
Medicare Patients
7,388
Medicare Billing
$575,642
Payment Breakdown by Category
Food & Beverage$4,947 (96.1%)
Education$125.50 (2.4%)
Gifts$75.00 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,947 | 175 | 96.1% |
| Education | $125.50 | 5 | 2.4% |
| Gift | $75.00 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,730 | 65 | $0 (2022) |
| ABBVIE INC. | $922.75 | 36 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $562.66 | 17 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $423.46 | 17 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $416.34 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $218.23 | 11 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $216.88 | 4 | $0 (2017) |
| Alcon Vision LLC | $123.95 | 4 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $117.74 | 8 | $0 (2021) |
| GENZYME CORPORATION | $100.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $572.84 | 29 | ABBVIE INC. ($268.11) |
| 2023 | $551.71 | 23 | AbbVie Inc. ($231.62) |
| 2022 | $577.50 | 16 | ABBVIE INC. ($423.02) |
| 2021 | $886.56 | 35 | Allergan, Inc. ($559.36) |
| 2020 | $636.70 | 32 | Allergan, Inc. ($450.17) |
| 2019 | $750.95 | 20 | Allergan Inc. ($357.64) |
| 2018 | $640.97 | 18 | Bausch & Lomb, a division of Bausch Health US, LLC ($268.44) |
| 2017 | $530.32 | 9 | Allergan Inc. ($239.14) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: EYE CARE | ||||||
| 12/04/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: EYE CARE | ||||||
| 10/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: EYE CARE | ||||||
| 10/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: EYE CARE | ||||||
| 10/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: Ophthalmology | ||||||
| 09/26/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: EYE CARE | ||||||
| 09/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: EYE CARE | ||||||
| 09/19/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $115.42 | General |
| Category: EYE CARE | ||||||
| 09/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: EYE CARE | ||||||
| 06/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: EYE CARE | ||||||
| 06/05/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: EYE CARE | ||||||
| 05/30/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: EYE CARE | ||||||
| 05/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: EYE CARE | ||||||
| 05/07/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Ophthalmology | ||||||
| 04/16/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Ophthalmology | ||||||
| 04/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: EYE CARE | ||||||
| 03/18/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,486 | 1,734 | $387,545 | $112,313 |
| 2022 | 15 | 1,678 | 1,920 | $441,015 | $131,467 |
| 2021 | 15 | 2,059 | 2,413 | $509,450 | $159,098 |
| 2020 | 15 | 2,165 | 2,599 | $539,940 | $172,764 |
Total Patients
7,388
Total Services
8,666
Medicare Billing
$575,642
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 331 | 374 | $65,450 | $29,451 | 45.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 294 | 434 | $65,100 | $25,592 | 39.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 33 | 51 | $112,200 | $20,798 | 18.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 233 | 241 | $40,970 | $10,587 | 25.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 295 | 308 | $30,800 | $7,448 | 24.2% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 20 | 28 | $26,600 | $4,885 | 18.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 18 | 20 | $16,000 | $4,532 | 28.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 51 | 51 | $12,750 | $4,285 | 33.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 96 | 107 | $4,815 | $2,012 | 41.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 34 | 34 | $6,800 | $985.84 | 14.5% |
| 92134 | Imaging of retina | Office | 2023 | 19 | 22 | $2,200 | $562.18 | 25.6% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 12 | 12 | $1,500 | $533.60 | 35.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $960.00 | $345.85 | 36.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 39 | 40 | $1,400 | $296.45 | 21.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 396 | 437 | $76,475 | $35,170 | 46.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 360 | 507 | $76,050 | $29,520 | 38.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 32 | 47 | $103,400 | $18,461 | 17.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 247 | 250 | $42,500 | $10,463 | 24.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 310 | 316 | $31,600 | $8,162 | 25.8% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 11 | 14 | $35,000 | $8,105 | 23.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 27 | 31 | $24,800 | $7,853 | 31.7% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2022 | 19 | 23 | $21,850 | $4,257 | 19.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 46 | 46 | $9,800 | $3,921 | 40.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 95 | 107 | $4,815 | $2,079 | 43.2% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 32 | 38 | $7,300 | $1,290 | 17.7% |
About Dr. Deborah Alexander, M.D
Dr. Deborah Alexander, M.D is a Ophthalmology healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306844097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Alexander, M.D has received a total of $5,148 in payments from pharmaceutical and medical device companies, with $572.84 received in 2024. These payments were reported across 182 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,947).
As a Medicare-enrolled provider, Alexander has provided services to 7,388 Medicare beneficiaries, totaling 8,666 services with total Medicare billing of $575,642. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Specialist
- Location Weslaco, TX
- Active Since 07/07/2005
- Last Updated 04/06/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1306844097
Products in Payments
- DURYSTA (Drug) $996.67
- LUMIGAN (Drug) $810.35
- VYZULTA (Drug) $546.85
- XIIDRA (Drug) $312.19
- One Series Ultra IOL Delivery System (Device) $192.73
- BESIVANCE (Drug) $157.68
- One Series Ultra (Device) $119.68
- MIEBO (Drug) $119.49
- CERDELGA (Drug) $100.00
- CyPass (Device) $98.48
- RESTASIS MULTIDOSE (Drug) $90.12
- LOTEMAX GEL (Drug) $82.04
- XEN (Device) $62.68
- Tecnis IOL (Device) $59.63
- ARGOS (Device) $58.14
- Rocklatan (Drug) $52.79
- RESTASIS (Drug) $49.59
- COMBIGAN (Drug) $49.53
- VUITY (Drug) $48.18
- rocklatan (Drug) $44.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.